U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H12N2
Molecular Weight 100.1622
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N-Methylpiperazine

SMILES

CN1CCNCC1

InChI

InChIKey=PVOAHINGSUIXLS-UHFFFAOYSA-N
InChI=1S/C5H12N2/c1-7-4-2-6-3-5-7/h6H,2-5H2,1H3

HIDE SMILES / InChI

Molecular Formula C5H12N2
Molecular Weight 100.1622
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
[Synthesis and pharmacological activity of amides and ozonolysis product of maleopimaric acid].
2011-02-15
Tetrasubstituted naphthalene diimide ligands with selectivity for telomeric G-quadruplexes and cancer cells.
2010-11-15
Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds.
2010-09-15
In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.
2010-09-14
Peptidyl alpha-ketoamides with nucleobases, methylpiperazine, and dimethylaminoalkyl substituents as calpain inhibitors.
2010-09-09
Chalcogenides of the aminomethylphosphines derived from 1-methylpiperazine, 1-ethylpiperazine and morpholine: NMR, DFT and structural studies for determination of electronic and steric properties of the phosphines.
2010-08-28
catena-Poly[(S)-2-methyl-piperazine-1,4-diium [[trichloridobismuthate(III)]-di-μ-chlorido]].
2010-08-11
Determination of individual proton affinities of ofloxacin from its UV-Vis absorption, fluorescence and charge-transfer spectra: effect of inclusion in beta-cyclodextrin on the proton affinities.
2010-08-05
[Synthesis, modifications, and antimicrobial activity of the methylpiperazinyl amides of triterpenic acids].
2010-07-21
Crystal Structures of TbCatB and rhodesain, potential chemotherapeutic targets and major cysteine proteases of Trypanosoma brucei.
2010-06-08
A statistics-based platform for quantitative N-terminome analysis and identification of protease cleavage products.
2010-05
Streamlined, automated protocols for the production of milligram quantities of untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) using AKTAxpress.
2010-05
Synthesis and antimicrobial activities of some new 1,2,3-triazole derivatives.
2010-04-08
Conjugate addition of nucleophiles to the vinyl function of 2-chloro-4-vinylpyrimidine derivatives.
2010-03-19
Sulfonamide-1,2,4-thiadiazole derivatives as antifungal and antibacterial agents: synthesis, biological evaluation, lipophilicity, and conformational studies.
2010-02
Detection of nitric oxide in tissue samples by ESI-MS.
2010-02
Synthesis and biological evaluation of N-hydroxyphenylacrylamides and N-hydroxypyridin-2-ylacrylamides as novel histone deacetylase inhibitors.
2010-01-28
Imatinibium dipicrate.
2010-01-20
Theoretical and experimental studies of the isomeric protonation in solution for a prototype aliphatic ring containing two nitrogens.
2010-01-14
Novel imatinib derivatives with altered specificity between Bcr-Abl and FMS, KIT, and PDGF receptors.
2010-01
Solution structure of a covalently bound pyrrolo[2,1-c][1,4]benzodiazepine-benzimidazole hybrid to a 10mer DNA duplex.
2009-12-29
Proteomics: challenges, techniques and possibilities to overcome biological sample complexity.
2009-12-08
[2-(4-Methyl-piperazin-1-ylmeth-yl)phen-yl]diphenyl-phosphane.
2009-11-25
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
2009-09-30
Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib.
2009-09-21
Regioselective reaction: synthesis and pharmacological study of Mannich bases containing ibuprofen moiety.
2009-09
Synthesis of some new 1,3,4-thiadiazol-2-ylmethyl-1,2,4-triazole derivatives and investigation of their antimicrobial activities.
2009-07
Discovery of substituted N'-(2-oxoindolin-3-ylidene)benzohydrazides as new apoptosis inducers using a cell- and caspase-based HTS assay.
2009-05-15
Manipulation of fluorescent and colorimetric changes of fluorescein derivatives and applications for sensing silver ions.
2009-03-14
Synthesis of some new 1,2,4-triazoles, their Mannich and Schiff bases and evaluation of their antimicrobial activities.
2009-03
The structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2).
2009-02-24
Development and targeted use of nilotinib in chronic myeloid leukemia.
2009-02-06
Synthesis and spectral characterization of a new class of N-(N-methylpiperazinoacetyl)-2,6-diarylpiperidin-4-ones: antimicrobial, analgesic and antipyretic studies.
2009-02
Structure elucidation of thioketone analogues of sildenafil detected as adulterants in herbal aphrodisiacs.
2009-01-15
Hoechst 33342: the dye that enabled differentiation of living X-and Y-chromosome bearing mammalian sperm.
2009-01-01
The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism.
2009
Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands.
2008-10-23
Improved proteome coverage by using iTRAQ labelling and peptide OFFGEL fractionation.
2008-10-13
Refining targeted therapies in chronic myeloid leukemia: development and application of nilotinib, a step beyond imatinib.
2008-10-01
Copper(I) cyanide networks: synthesis, structure, and luminescence behavior. Part 2. Piperazine ligands and hexamethylenetetramine.
2008-08-04
Use of N-methylpiperazine for the preparation of piperazine-based unsymmetrical bis-ureas as anti-HIV agents.
2008-07
Determination of analogs of sildenafil and vardenafil in foods by column liquid chromatography with a photodiode array detector, mass spectrometry, and nuclear magnetic resonance spectrometry.
2008-06-24
Morpholine-based immonium and halogenoamidinium salts as coupling reagents in Peptide synthesis1.
2008-04-04
3-(4-Methyl-piperazin-1-yl)isobenzofuran-1(3H)-one.
2008-04-02
Synthesis and Pharmacological Evaluation of (6-Substituted 4-Oxo-4H-chromene-3 yl) methyl N-substituted Aminoacetates.
2008-01
Crystal structures of the FAK kinase in complex with TAE226 and related bis-anilino pyrimidine inhibitors reveal a helical DFG conformation.
2008
N-Methyl-piperazinediium penta-chloridoanti-monate(III) monohydrate.
2007-12-12
NS-187 (INNO-406), a Bcr-Abl/Lyn dual tyrosine kinase inhibitor.
2007-11-14
Synthesis of o-sulfamidotriazobenzenes from 1,1'-sulfonylbis(benzotriazole).
2007-07-20
Precise protein quantification based on peptide quantification using iTRAQ.
2007-06-21
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:36:17 GMT 2025
Edited
by admin
on Mon Mar 31 19:36:17 GMT 2025
Record UNII
B92I95EL9Q
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
N-Methylpiperazine
Systematic Name English
Cyclizine related ocmpound A
USP-RS  
Preferred Name English
Piperazine, 1-methyl-
Systematic Name English
1-Methylpiperazine
Systematic Name English
1-Methylpiperazine [USP IMPURITY]
Common Name English
Cyclizine related ocmpound A [USP-RS]
Common Name English
NSC-30195
Code English
NSC-30675
Code English
1-Methyl-1,4-piperazine
Common Name English
Diethylcarbamazine citrate impurity A [EP IMPURITY]
Common Name English
Code System Code Type Description
WIKIPEDIA
Methylpiperazine
Created by admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
PRIMARY
NSC
30195
Created by admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
PRIMARY
PUBCHEM
53167
Created by admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
PRIMARY
ECHA (EC/EINECS)
203-639-5
Created by admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
PRIMARY
EPA CompTox
DTXSID4021898
Created by admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
PRIMARY
RS_ITEM_NUM
1154015
Created by admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
PRIMARY
NSC
30675
Created by admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
PRIMARY
FDA UNII
B92I95EL9Q
Created by admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
PRIMARY
MESH
C048073
Created by admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
PRIMARY
CAS
109-01-3
Created by admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (GC)
USP